Edivoxetine
Edivoxetine, also known as LY2216684, is is a selective norepinephrine reuptake inhibitor under development for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant treatment. It was in phase III clinical trials, in 2012, for major depressive disorder, but failed to get approval.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD004 |
| CAS # | 1194508-25-2 (free base) |
| Pricing | Customizable size, Inquiry |
| Synonym | LY2216684; LY-2216684; LY 2216684; Edivoxetine |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C18H26FNO4 |
| Exact Mass | 339.1846 |
| Molecular Weight | 339.4074 |
| Elemental Analysis | C, 63.70; H, 7.72; F, 5.60; N, 4.13; O, 18.86 |
| IUPAC/Chemical Name | (R)-2-(5-fluoro-2-methoxyphenyl)-1-((S)-morpholin-2-yl)-1-(tetrahydro-2H-pyran-4-yl)ethan-1-ol |
| InChi Key | CPBHSHYQQLFAPW-ZWKOTPCHSA-N |
| InChi Code | InChI=1S/C18H26FNO4/c1-22-16-3-2-15(19)10-13(16)11-18(21,14-4-7-23-8-5-14)17-12-20-6-9-24-17/h2-3,10,14,17,20-21H,4-9,11-12H2,1H3/t17-,18+/m0/s1 |
| SMILES Code | O[C@@](C1CCOCC1)(CC2=CC(F)=CC=C2OC)[C@@H]3CNCCO3 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO, not in water |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |
| Class-2 | Depression |
| Availability | 2 Weeks |